Cluster of differentiation 24 monoclonal antibody induces apoptosis in the osteosarcoma cells

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 14, 2014, Pages 2038-2041

  Zhang, Y H ^a   Wang, Z Y ^a   Hao, F Y ^b   Zhang, L ^b  

^a Department of Orthopedics Yishui Central Hospital ^*  (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Apoptosis; CD24; Monoclonal antibody; Osteosarcoma

Indexed keywords

CLUSTER OF DIFFERENTIATION 24; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD24; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; CD24 ANTIGEN; CD24 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; BONE NEOPLASMS; CELL DIFFERENTIATION; DRUG EFFECTS; DRUG SCREENING; IMMUNOLOGY; MOLECULARLY TARGETED THERAPY; NUDE MOUSE; PATHOLOGY; RANDOMIZATION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD24; APOPTOSIS; BONE NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MICE; MICE, NUDE; MOLECULAR TARGETED THERAPY; OSTEOSARCOMA; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84940293923     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. KIM K, MIN HS, CHIE EK, JANG JY, KIM SW, HAN SW, OH DY, IM SA, KIM TY, BANG YJ, JANG JJ, HA SW. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.World J Gastroenterol 2013; 19: 1438-1443
2. MILLER E, SHAPIRA S, GUR E, NAUMOV I, KAZANOV D, LESHEM D, BARNEA Y, MESHIACH Y, GAT A, SION D, ARBER N, KRAUS S. Increased expression of CD24 in nonmelanoma skin cancer. Int J Biol Markers 2012; 27: e331-336.
3. KRISTIANSEN G. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 2002; 161: 1215-1221.
4. KURE S, MATSUDA Y, HAGIO M, UEDA J, NAITO Z, ISHIWATA T. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Int J Oncol 2012; 41: 1314-1324.
5. JACOB J. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 2004; 4: 454-460
6. SHI Y, GONG HL, ZHOU L, TIAN J, WANG Y. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2012; 74: 78-85.
7. BERNARDI MA, LOGULLO AF, PASINI FS, NONOGAKI S, BLUMKE C, SOARES FA, BRENTANI MM. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer. Oncol Rep 2012; 27: 28-38.
8. YANG XR, XU Y, YU B, ZHOU J, LI JC, QIU SJ, SHI YH, WANG XY, DAI Z, SHI GM, WU B, WU LM, YANG GH, ZHANG BH, QIN WX, FAN J. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.Clin Cancer Res 2009; 15: 5518-5527.
9. TAKAHASHI M, NAKAJIMA M, OGATA H, DOMEKI Y, OHTSUKA K, IHARA K, KURAYAMA E, YAMAGUCHI S, SASAKI K, MIYACHI K, KATO H. CD24 Expression is associated with progression of gastric cancer. Hepatogastroenterology 2012; 60: 653-658.
10. TANG J, CAI H, LIN L, XUE P, ZHONG W, TANG M. Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.Clin Transl Oncol 2013; 15: 541-547.
11. BRETZ N, NOSKE A, KELLER S, ERBE-HOFMANN N, SCHLANGE T, SALNIKOV AV, MOLDENHAUER G, KRISTIANSEN G, ALTEVOGT P. CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion. Clin Exp Metastasis 2012; 29: 27-38.
12. JU JH, JANG K, LEE KM, KIM M, KIM J, YI JY, NOH DY, SHIN I. CD24 enhances DNA damage-induced apoptosis by modulating NF-B signaling in CD44-expressing breast cancer cells. Carcinogenesis 2011; 32: 1474-1483.
13. SU D, DENG H, ZHAO X, ZHANG X, CHEN L, CHEN X, LI Z, BAI Y, WANG Y, ZHONG Q, YI T, QIAN Z, WEI Y. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA. Cytotherapy 2009; 11: 642-652.
14. SMITH SC, OXFORD G, WU. The metastasisassociated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 2006; 66: 1917-1922.
15. CHAPPEL MS, HOUGH MR, MITTEL A, TAKEI F, KAY R, HUMPHRIES RK. Cross-linking the murine heat-stable antigen induces apoptosis in B cell precursors and suppresses the anti-CD40-induced proliferation of mature resting B lymphocytes. J Exp Med 1996; 184: 1638-1649.
16. TAGUCHI T, KIYOKAWA N, MIMORI K, SUZUKI T, SEKINO T, NAKAJIMA H, SAITO M, KATAGIRI YU, MATSUO N, MATSUO Y, KARASUYAMA H, FUJIMOTO J. Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol 2003; 170: 252-260.
17. SAGIV E, MEMEO L, KARIN A, KAZANOV D, JACOBHIRSCH J, MANSUKHANI M, RECHAVI G, HIBSHOOSH H, ARBER N. CD24 is a new oncogene, early at the multi-step process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131: 630-639.
18. SAGIV E, KAZANOV D, ARBER N. CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother 2006; 60: 280-284.
19. EYAL S, ALEX S, URI ROZOVSKI, RAMI K, PETER A, TIMOTHY W, NADIR A. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res 2008; 68: 2803-2812.
20. DURANDY A, BROUSSE N, ROZENBERG F, DE SAINT BASILE G, FISCHER A, FISCHER A. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest 1992; 30: 945-952.
21. KRISTIANSEN G, SAMMAR M, ALTEVOGT P. Tumor biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004; 35: 255-262.
22. WEBER E, LEHMANN HP, BECK-SICKINGER AG, WAWRZYNCZAK EJ, WAIBEL R, FOLKERS G, STAHEL RA. Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leukocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanineproline. Clin Exp Immunol 1993; 93: 279-285.
23. FISCHER A, BLANCHE S, LE BIDOIS J, BORDIGONI P, GARNIER JL, NIAUDET P. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324: 1451-1456.
24. BENKERROU M, JAIS JP, LEBLOND V, DURANDY A, SUTTON L, BORDIGONI P. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and longterm outcome. Blood 1998; 92: 3137-3147.
25. SAGIV E, STARR A, ROZOVSKI U, KHOSRAVI R, ALTEVOGT P, WANG T. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res 2008; 68: 2803-2812.